💡 Quick answer
The landmark clinical studies, treatment history and latest research for Rosemary oil for hair loss — fact-checked and sourced.
Research & evidence
How treatment evolved
1988FDA approves 2% topical minoxidil (Rogaine, Upjohn) for androgenetic alopecia in men — the first drug approved for hair loss, establishing minoxidil as the benchmark comparator.
1991FDA approves 2% topical minoxidil for women with female pattern hair loss, extending the approved indication beyond men.
19962% topical minoxidil is switched to over-the-counter (OTC) status in the US (February 1996), making it widely available without prescription.
2014FDA approves 5% minoxidil foam once daily for women with female pattern hair loss (already approved for men), reflecting accumulated higher-strength efficacy data.
2015Panahi et al. publish a randomized comparative human trial of rosemary oil vs minoxidil 2% in androgenetic alopecia (Skinmed 2015;13:15-21), the pivotal source behind 'rosemary rivals minoxidil' claims. (Note: trial was conducted in men; 'first and still the only' is a popular framing, so wording softened from 'first and still the only head-to-head.')
2016Cochrane systematic review (van Zuuren et al., May 2016, CD007628.pub4) of interventions for female pattern hair loss confirms minoxidil's efficacy across multiple RCTs; no botanical such as rosemary reaches that evidence tier.
Key clinical studies
Panahi et al., 20152015
Randomized comparative (active-controlled, single-blind assessor) trial; 100 patients with androgenetic alopecia, 6-month follow-up; rosemary oil vs minoxidil 2%, each applied twice daily
Both groups showed a statistically significant increase in hair count at 6 months versus baseline, with no significant difference between rosemary oil and minoxidil 2% at the 6-month endpoint; neither showed a significant change at 3 months. Scalp itching was significantly less frequent in the rosemary group. Limitations: single small trial, no true placebo arm, low/moderate strength of evidence, and it used only the weaker 2% minoxidil.
Skinmed 2015;13(1):15-21
van Zuuren et al. (Cochrane), 20162016
Cochrane systematic review of interventions for female pattern hair loss; 47 RCTs, 5,290 participants (minoxidil evaluated in ~17 trials)
Minoxidil produced at least moderate hair regrowth in roughly twice as many women as placebo and increased total hair count per cm2 versus placebo (moderate-quality evidence for minoxidil). Adverse events were mostly mild (itch, irritation, hypertrichosis). The review found no comparable RCT evidence base for rosemary oil, underscoring that botanical claims rest on far weaker data than minoxidil.
Cochrane Database of Systematic Reviews
Latest research: Recent work (2023-2026) has moved from the single 2015 head-to-head trial toward quantitative synthesis: systematic reviews and network meta-analyses of over-the-counter androgenetic alopecia treatments now pool rosemary against minoxidil and consistently rank minoxidil as significantly more effective (e.g., a 2025 network meta-analysis estimating ~19 more hairs/cm2 for minoxidil), while calling the rosemary evidence sparse and low-volume. In parallel, standardized rosemary-derived formulations and animal/mechanistic studies (e.g., DHT and 5-alpha-reductase pathways, scalp microcirculation) are being tested to define whether any reproducible human benefit exists beyond the lone 2015 RCT.
Summaries reflect published, peer-reviewed research and are not medical advice. See the linked sources for details.
Explore more
Self-check →Treatments →Transplant →Women →New →Hair Loss Causes →Hair-Loss Glossary →Hair-Loss Questions & Answers →Hair-Loss Ingredient Evidence Ratings →Hair Transplant Cost by City →Research →Browse all →
Not medical advice. General education only; it does not replace diagnosis or treatment by a licensed professional. Consult a board-certified dermatologist before starting, stopping or changing any treatment.
⚠️ When to see a doctor — don’t self-treat
- Sudden patchy or circular bald spots
- Redness, scaling, pus, pain or itch (possible scarring alopecia — treat urgently)
- Broken hairs or rapid loss
- Loss with body-wide signs (weight loss, fatigue, cycle changes, acne, extra hair)
- Loss right after a new medication
- Any hair loss in a child